FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 100 mg/10 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 100 mg/10 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ropivacaine; Epinephrine; Clonidine; Ketorolac | 2.46 mg/50 mL; .005 mg/50 mL; .0008 mg/50 mL; .3 mg/50 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ropivacaine; Epinephrine; Clonidine; Ketorolac | 2.46 mg/50 mL; .005 mg/50 mL; .0008 mg/50 mL; .3 mg/50 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 20 mg/5 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 20 mg/5 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 20 mg/5 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 20 mg/5 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 20 mg/5 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 20 mg/5 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 20 mg/5 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 20 mg/5 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 60 g/3000 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 20 mg/5 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 20 mg/5 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 20 mg/10 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 60 g/3000 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine | 20 mg/5 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 2 g/500 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.75 g/250 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Cefazolin | 1 g/10 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Cefazolin | 300 g/3000 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.5 g/500 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.5 g/250 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1 g/250 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.25 g/250 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Cefazolin | 2 g/100 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Cefazolin | 3 g/100 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vasopressin | 5 U/5 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Dextrose | 1500 g/3000 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Epinephrine | 100 ug/10 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Epinephrine | 5 mg/250 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Fentanyl | 1000 ug/100 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Fentanyl Citrate | 2000 ug/100 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Fentanyl Citrate | 1 mg/100 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Fentanyl Citrate | 1000 ug/50 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Fentanyl Citrate | 2500 ug/250 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Heparin | 50 U/50 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Heparin | 20 U/20 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Hydromorphone Hydrochloride | 6 mg/30 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Hydromorphone Hydrochloride | 25 mg/50 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Hydromorphone Hydrochloride | 10 mg/50 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Amiodarone | 5.4 g/3000 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Hydromorphone Hydrochloride | 50 mg/50 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Amiodarone Hydrochloride | 450 mg/250 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Amiodarone Hydrochloride | 900 mg/500 mL | 2022-2 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Amiodarone Hydrochloride | 900 mg/500 mL | 2022-2 | source_no_ndc | 2026-11-08 |